NPI: 1194718304 · PEARISBURG, VA 24134 · Multi-Specialty Clinic/Center · NPI assigned 08/24/2005
Authorized official PRESCOTT, ELEANOR controls 20+ related entities in our dataset. Read more
| Authorized Official | PRESCOTT, ELEANOR (GOVERNMENT PROGRAM MANAGER) |
| NPI Enumeration Date | 08/24/2005 |
Other providers sharing the same authorized official: PRESCOTT, ELEANOR
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,402 | $604K |
| 2019 | 15,512 | $961K |
| 2020 | 18,888 | $1.34M |
| 2021 | 21,843 | $1.46M |
| 2022 | 22,472 | $1.65M |
| 2023 | 24,937 | $2.12M |
| 2024 | 22,178 | $2.17M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 9,526 | 8,557 | $2.11M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 10,142 | 8,895 | $1.98M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4,506 | 3,791 | $1.22M |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,199 | 1,966 | $804K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2,746 | 867 | $674K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,033 | 2,797 | $598K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,781 | 2,238 | $487K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,265 | 1,091 | $418K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,114 | 946 | $269K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2,403 | 2,224 | $222K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,096 | 967 | $151K |
| 80053 | Comprehensive metabolic panel | 7,705 | 6,547 | $136K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1,532 | 677 | $114K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4,583 | 3,859 | $87K |
| 71046 | Radiologic examination, chest; 2 views | 2,313 | 2,031 | $77K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 359 | 342 | $75K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,965 | 2,523 | $58K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 4,873 | 4,099 | $56K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,038 | 938 | $55K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 831 | 752 | $53K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 261 | 247 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9,042 | 7,427 | $47K |
| 97162 | 124 | 119 | $38K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 233 | 211 | $37K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 116 | 102 | $31K |
| 71045 | Radiologic examination, chest; single view | 3,143 | 2,594 | $28K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 4,428 | 3,403 | $26K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,650 | 1,374 | $23K |
| 84484 | 3,124 | 2,586 | $22K | |
| 73610 | 564 | 453 | $20K | |
| 97161 | 121 | 111 | $20K | |
| 83690 | 2,119 | 1,864 | $20K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 235 | 227 | $19K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 699 | 618 | $17K |
| 81001 | 3,206 | 2,867 | $16K | |
| 73030 | 354 | 286 | $16K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 770 | 709 | $15K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 43 | 38 | $14K |
| 73130 | 258 | 204 | $13K | |
| 83880 | 668 | 591 | $12K | |
| J8597 | Antiemetic drug, oral, not otherwise specified | 793 | 682 | $11K |
| 20610 | 287 | 243 | $11K | |
| 73630 | 308 | 246 | $10K | |
| 83735 | 2,234 | 1,908 | $10K | |
| 73110 | 187 | 142 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,363 | 1,277 | $9K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 2,364 | 2,079 | $8K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 201 | 168 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,051 | 2,605 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 715 | 615 | $7K |
| 76830 | Ultrasound, transvaginal | 45 | 43 | $7K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 112 | 101 | $6K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 308 | 262 | $6K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 2,164 | 1,994 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 16 | 15 | $6K |
| 81025 | 816 | 731 | $5K | |
| 84703 | 1,005 | 914 | $5K | |
| 73562 | 80 | 65 | $5K | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 59 | 55 | $4K |
| 36415 | Collection of venous blood by venipuncture | 2,042 | 1,548 | $4K |
| 83605 | 776 | 679 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1,839 | 1,623 | $4K |
| 87081 | 1,025 | 975 | $4K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 44 | 40 | $3K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 2,138 | 1,002 | $3K |
| J3490 | Unclassified drugs | 3,718 | 2,164 | $3K |
| 81003 | 743 | 688 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 15 | 13 | $2K |
| 82962 | 945 | 653 | $2K | |
| 72100 | 59 | 49 | $2K | |
| 74018 | 81 | 72 | $2K | |
| 96376 | 216 | 191 | $2K | |
| 73564 | 63 | 54 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 599 | 549 | $2K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 848 | 683 | $2K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 372 | 354 | $1K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 76 | 75 | $1K |
| 87040 | 75 | 66 | $1K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 18 | 16 | $864.74 |
| 85379 | 85 | 79 | $808.43 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 16 | 16 | $443.07 |
| 80306 | 125 | 113 | $373.66 | |
| 74019 | 30 | 25 | $311.43 | |
| 85610 | 46 | 43 | $221.64 | |
| 87186 | 26 | 24 | $152.51 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 12 | 12 | $114.17 |
| 82565 | 95 | 88 | $108.27 | |
| J2060 | Injection, lorazepam, 2 mg | 34 | 26 | $64.01 |
| 85730 | 16 | 15 | $27.36 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 131 | 121 | $27.19 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 50 | 49 | $20.82 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 26 | 24 | $14.83 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 58 | 52 | $7.06 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 113 | 99 | $2.49 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 12 | 12 | $1.65 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 17 | 17 | $0.68 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 304 | 223 | $0.09 |
| J2704 | Injection, propofol, 10 mg | 41 | 38 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 14 | 12 | $0.00 |
| J8540 | Dexamethasone, oral, 0.25 mg | 13 | 13 | $0.00 |